(Natural News) New research published in The New England Journal of Medicine (NEJM) suggests that a novel form of monoclonal antibodies could be a safe and effective cure for cancer. The results of the small trial are already being hailed as “remarkable” and “unprecedented” because all 18 participants are now cancer-free, thanks to receiving dostarlimab […]
in: alternative medicine,anti-cancer,breakthrough,cancer,cancer solutions,cancer treatment,discoveries,dostarlimab,goodcancer,goodhealth,goodmedicine,goodscience,immune system,monoclonal antibodies,NEJM,Oncology,research